Literature DB >> 30546590

Biventricular pacing and coronary sinus ICD lead implantation in a patient with a mechanical tricuspid valve replacement.

Neil T Srinivasan1,2, Oliver R Segal1.   

Abstract

A 49-year-old man was admitted with symptomatic, sustained monomorphic ventricular tachycardia. He had a previous history of AMP-kinase disease associated with hypertrophic cardiomyopathy and complete heart block, and a pre-existing dual chamber pacemaker. He also had a mechanical tricuspid valve replacement and mitral valve replacement, for severe tricuspid regurgitation from right ventricle (RV) lead-induced injury to the tricuspid valve and a fibroblastoma on the mitral valve. His pre-existing RV lead was maintained between the prosthetic valve annulus and the native annulus. Inability to place an implantable cardioverter-defibrillator (ICD) in the RV due to the presence of a mechanical tricuspid valve replacement represented a rare but challenging clinical scenario. Surgical epicardial lead placement or the use of a subcutaneous ICD (S-ICD) were possible alternatives. Traditional ICD lead placement was favored because of the broad QRS from RV pacing meaning that use of the S-ICD was not possible due to failure of the electrocardiogram to lie within the bounds of the screening template, and the perceived high risk of repeat thoracotomy. We describe the technique for ICD lead placement in a mid-lateral cardiac venous branch of the coronary sinus with the ability to deliver anti-tachycardia pacing and cardiac resynchronization. To our knowledge this is the first report of an ICD in the mid-lateral cardiac vein, with cardiac resynchronization. <Learning objective: This case describes the technique for implantable cardioverter-defibrillator placement in the coronary sinus with biventricular pacing in a patient with a mechanical tricuspid and pre-existing right ventricular endocardial lead. This technique represents a viable alternative to repeat thoracotomy and surgical lead placement, where the risks of complication, prolonged hospital stay and lead failure are high. It also offers the ability to deliver anti-tachycardia pacing and cardiac resynchronization.>.

Entities:  

Keywords:  AMP-kinase disease; Hypertrophic cardiomyopathy; Implantable cardioverter-defibrillator; Mechanical tricuspid valve replacement

Year:  2015        PMID: 30546590      PMCID: PMC6281873          DOI: 10.1016/j.jccase.2015.08.004

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  10 in total

1.  Modified implantation of a transvenous defibrillator in a patient after tricuspid valve replacement.

Authors:  C Schreiber; H Mehmanesch; C Kolb; C Schmitt; R Lange
Journal:  Pacing Clin Electrophysiol       Date:  2000-11       Impact factor: 1.976

2.  Lead configuration for defibrillator implantation in a patient with congenital heart disease and a mechanical prosthetic tricuspid valve.

Authors:  C T Leng; J E Crosson; H Calkins; R D Berger
Journal:  Pacing Clin Electrophysiol       Date:  2001-08       Impact factor: 1.976

3.  Implantable defibrillator in a patient with a tricuspid valve bioprosthesis.

Authors:  Todd Cohen; William Kokotos; Roger Kersten
Journal:  J Invasive Cardiol       Date:  2008-12       Impact factor: 2.022

4.  Risk of failure of transvenous implantable cardioverter-defibrillator leads.

Authors:  C Jan Willem Borleffs; Lieselot van Erven; Rutger J van Bommel; Enno T van der Velde; Ernst E van der Wall; Jeroen J Bax; Frits R Rosendaal; Martin J Schalij
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-04-17

5.  Permanent epicardial pacing in pediatric patients: seventeen years of experience and 1200 outpatient visits.

Authors:  M I Cohen; D M Bush; V L Vetter; R E Tanel; T S Wieand; J W Gaynor; L A Rhodes
Journal:  Circulation       Date:  2001-05-29       Impact factor: 29.690

6.  Transvenous cardioverter-defibrillator implantation in a patient with tricuspid mechanical prosthesis.

Authors:  Mauro Biffi; Matteo Bertini; Matteo Ziacchi; Giuseppe Boriani
Journal:  J Cardiovasc Electrophysiol       Date:  2007-03

7.  Longevity of Sprint Fidelis implantable cardioverter-defibrillator leads and risk factors for failure: implications for patient management.

Authors:  Robert G Hauser; William H Maisel; Paul A Friedman; Linda M Kallinen; Andrew S Mugglin; Kapil Kumar; David O Hodge; Thomas B Morrison; David L Hayes
Journal:  Circulation       Date:  2011-01-17       Impact factor: 29.690

8.  Long-term experience with subcutaneous ICD leads: a comparison among three different types of subcutaneous leads.

Authors:  Klaus Kettering; Christian Mewis; Volker Dörnberger; Reinhard Vonthein; Ralph F Bosch; Ludger Seipel; Volker Kühlkamp
Journal:  Pacing Clin Electrophysiol       Date:  2004-10       Impact factor: 1.976

9.  Azygos vein lead implantation for high defibrillation thresholds in implantable cardioverter defibrillator placement.

Authors:  Naga Va Kommuri; Sri Lakshmi S Kollepara; E Saulitis; Ma Siddiqui
Journal:  Indian Pacing Electrophysiol J       Date:  2010-01-07

10.  Implantable cardioverter defibrillator lead placement in the middle cardiac vein after tricuspid valve surgery.

Authors:  J Alberto Lopez
Journal:  Europace       Date:  2012-02-14       Impact factor: 5.214

  10 in total
  1 in total

1.  Simultaneous pacing from two branches of coronary sinus in a patient with prosthetic tricuspid valve and complete heart block.

Authors:  Mustafa Yolcu
Journal:  BMC Cardiovasc Disord       Date:  2020-02-10       Impact factor: 2.298

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.